food-and-drug-law

Documents about food-and-drug-law

• Has the "M" Word Been Framed? Marijuana, Cannabis and Public Opinion#345837Scholarship@Vanderbilt Law
• CLEOPATRA'S NEEDLE: THE HISTORY AND LEGACY OF SILICONE INJECTIONS#485735Harvard DASH
• Biotechnology Patent Law Top Ten Of 2020: Valeant Victorious, Falling Eagle, and Successful Slayback#1022013Texas A&M Law Scholarship
• 21 U.S.C. § 467f — Federal Food, Drug, and Cosmetic Act applications#577178US Code (LII)
• 21 U.S.C. § 399i — Food and Drug Administration Working Capital Fund#577203US Code (LII)
• Sustainable Agriculture, Patent Rights, and Plant Innovation#494050Digital Repository @ Maurer Law
• Global Responses: The Search for Cures in the Development of Pharmaceuticals#493930Digital Repository @ Maurer Law
• Genetically Modified Organisms in Peasant Farming: Social Impact and Equity#494054Digital Repository @ Maurer Law
• Regulations on Biotechnological Research and Biologically Modified Products#485747Harvard DASH
• Hydra: Lessons from the world's largest darknet market#372601Texas A&M Law Scholarship
• Baptists, Bootleggers & Electronic Cigarettes#394054William & Mary Law School Scholarship Repository
• 21 U.S.C. § 2242 — Foreign offices of the Food and Drug Administration#576861US Code (LII)
• 21 U.S.C. § 679 — Application of Federal Food, Drug, and Cosmetic Act#577118US Code (LII)
• Portion Distortion and Public Perception: How Serving Size Guidelines are Over-Serving and Under-Serving the Consumer#485762Harvard DASH
• Seeds of Rebellion#168663Digital Commons @ American University Washington College of Law
• We Need a Cole Memorandum for Magic Mushrooms#345822Scholarship@Vanderbilt Law
• <i>Hester</i>’s Dubious Roots and Legacy: Open Fields Doctrine Under Scrutiny#372529Scholarship @ GEORGETOWN LAW
• The Image and Politics of Coca-Cola: From the Early Years to the Present#485753Harvard DASH
• Legislation--The Fair Packaging and Labeling Act: Its Legislative History, Content, and Future#258817Scholarship@Vanderbilt Law
• 21 U.S.C. § 379dd-2 — Activities of the Food and Drug Administration#577242US Code (LII)
• The Opioid Crisis or Climate Change: Which Is More Likely to Succeed Under the Tobacco Litigation Model?#1021948Texas A&M Law Scholarship
• Better Fighting Through Chemistry? The Role of FDA Regulation in Crafting the Warrior of the Future#485763Harvard DASH
• Vaccines and The National Vaccine Injury Compensation Program#485739Harvard DASH
• Effects of Sunday Sales Restrictions on Overall and Day-Specific Alcohol Consumption: Evidence from Canada#345845Scholarship@Vanderbilt Law
• Trans Fat: Can New York City Save Its Citizens From This "Metabolic Poison"?#181431Digital Commons @ University of Georgia School of Law
• A View From Inside Industry: A Response to Professor Walker's Challenges#493934Digital Repository @ Maurer Law
• An Untapped Resource in Addressing Emerging Infectious Diseases: Traditional Healers#493964Digital Repository @ Maurer Law
• Food and Drug Administration's regulation of dietary supplements : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, July 20, 1993#334152Internet Archive
• Introduction: Syncopated Sustainable Development (Sustainable Development, Agriculture, and the Challenge of Genetically Modified Organisms Symposium)#494047Digital Repository @ Maurer Law
• Trust, Transparency, and the Fragile Promise of Data Governance in the Era of Modernization#278078Texas A&M Law Scholarship
• The American People and the Medical Establishment: A History of Mistrust#168664Digital Commons @ American University Washington College of Law
• In Pursuit of Profitability and Effectiveness in the Global Pharmaceutical Industry: Comments on Professor Walker's Four Challenges#493931Digital Repository @ Maurer Law
• Gently Down the Stream: How Exploding Steamboat Boilers in the 19th Century Ignited Federal Public Welfare Regulation [REDACTED VERSION]#485756Harvard DASH
• A Penny for Your Thoughts: Private and Collective Contracting for Traditional Medicinal Knowledge Modeled on Bioprospecting Contracts in Costa Rica#181416Digital Commons @ University of Georgia School of Law
• State Mifepristone Regulation Following GenBioPro v Raynes#168659Digital Commons @ American University Washington College of Law
• Practicing Medicine in the Culture Wars — Gender-Affirming Care and the Battles Over Clinician Autonomy#309819Scholarly Commons at Boston University School of Law
• The Plan B for Plan B: The New Dual Over-the-Counter and Prescription Status of Plan B and Its Impact upon Pharmacists, Consumers, and Conscience Clauses#181425Digital Commons @ University of Georgia School of Law
• Patient Access in Fourteen High-Income Countries to New Antibacterials Approved by the FDA, EMA, PMDA, or Health Canada, 2010-2020#309799Scholarly Commons at Boston University School of Law
• Glamorization or Condemnation: The Accuracy of Hollywood&acirc;&euro;&trade;s Portrayal of Heroin Use in Motion Pictures in the 1990&acirc;&euro;&trade;s#485766Harvard DASH